Xtant Medical Q4 GAAP EPS $(0.03) Misses $(0.02) Estimate, Sales $28.11M Beat $26.55M Estimate
Xtant Medical Q4 GAAP EPS $(0.03) Misses $(0.02) Estimate, Sales $28.11M Beat $26.55M Estimate
Xtant Medical第四季度GAAP每股收益（0.03美元）未达到预期（0.02美元），销售额为2811万美元，超过2655万美元的预期
Xtant Medical Hldgs (AMEX:XTNT) reported quarterly losses of $(0.03) per share which missed the analyst consensus estimate of $(0.02) by 50 percent. This is a 50 percent decrease over losses of $(0.02) per share from the same period last year. The company reported quarterly sales of $28.11 million which beat the analyst consensus estimate of $26.55 million by 5.87 percent. This is a 84.07 percent increase over sales of $15.27 million the same period last year.
Xtant Medical Hldgs（美国证券交易所股票代码：XTNT）公布的季度亏损为每股0.03美元（0.03美元），比分析师普遍预期的0.02美元（0.02美元）低50％。这比去年同期每股亏损0.02美元（0.02）下降了50％。该公司公布的季度销售额为2811万美元，比分析师普遍预期的2655万美元高出5.87％。这比去年同期的1,527万美元销售额增长了84.07％。